Fluoxetine Hydrochloride Patent Expiration
Fluoxetine Hydrochloride is Used for treating depression and minimizing nausea side effects. It was first introduced by Eli Lilly And Co
Fluoxetine Hydrochloride Patents
Given below is the list of patents protecting Fluoxetine Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Prozac Weekly |
US5910319 (Pediatric) | Fluoxetine enteric pellets and methods for their preparation and use |
Nov 29, 2017
(Expired) | Lilly |
| Prozac Weekly |
US5985322 (Pediatric) | Method for the treatment of CNS disorders |
Nov 29, 2017
(Expired) | Lilly |
| Prozac | US6960577 | Combination therapy for treatment of refractory depression |
Nov 01, 2017
(Expired) | Eli Lilly And Co |
| Prozac Weekly | US5910319 | Fluoxetine enteric pellets and methods for their preparation and use |
May 29, 2017
(Expired) | Lilly |
| Prozac Weekly | US5985322 | Method for the treatment of CNS disorders |
May 29, 2017
(Expired) | Lilly |
| Prozac Weekly | USRE39030 | Fluoxetine enteric pellets and methods for their preparation and use |
May 29, 2017
(Expired) | Lilly |
A patent's expiry date may change depending upon legal activities going on that patent. Critical
activities like
abandoning of a patent, term extension of a patent or amendment of its claims can increase or
decrease the life of a
patent hence affecting its expiry date and in turn affecting the generic launch date of that
drug. Tracking these
ongoing activities on a patent application helps to keep an eye on the latest developments in
the patent process of
the drug which can give an idea of how early a drug's generic could be available. The next
section provides a list
of recent legal activities on Fluoxetine Hydrochloride's patents.
Latest Legal Activities on Fluoxetine Hydrochloride's Patents
Given below is the list recent legal activities going on the following patents of Fluoxetine Hydrochloride.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Patent Issue Date Used in PTA Calculation Critical
| 01 Nov, 2005 | US6960577 |
| Recordation of Patent Grant Mailed Critical
| 01 Nov, 2005 | US6960577 |
| Issue Notification Mailed Critical
| 12 Oct, 2005 | US6960577 |
| Receipt into Pubs | 06 Oct, 2005 | US6960577 |
| Dispatch to FDC | 05 Oct, 2005 | US6960577 |
| Application Is Considered Ready for Issue Critical
| 13 Aug, 2005 | US6960577 |
| Issue Fee Payment Verified Critical
| 05 Jul, 2005 | US6960577 |
| Issue Fee Payment Received Critical
| 05 Jul, 2005 | US6960577 |
| Mail Examiner's Amendment | 02 Jun, 2005 | US6960577 |
| Mail Notice of Allowance Critical
| 02 Jun, 2005 | US6960577 |
Fluoxetine Hydrochloride's Family Patents
